Geode Capital Management, LLC Dia Medica Therapeutics Inc. Transaction History

Geode Capital Management, LLC

$1.21 Trillion
Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 306,958 shares of DMAC stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

306,958

Previous 236,888 29.58%

Holding current value

$1.64 Million

Previous $698,000 84.24%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$2.8 - $4.49 $196,196 - $314,614	70,070 Added 29.58%	306,958 $1.29 Million
Q2 2024 Aug 09, 2024	SELL	$2.16 - $3.66 $5,069 - $8,590	-2,347 Reduced 0.98%	236,888 $698,000
Q1 2024 May 13, 2024	BUY	$2.58 - $3.23 $52,779 - $66,076	20,457 Added 9.35%	239,235 $662,000
Q3 2023 Nov 13, 2023	BUY	$2.56 - $4.4 $86,804 - $149,195	33,908 Added 18.34%	218,778 $564,000
Q4 2022 Feb 13, 2023	SELL	$1.13 - $1.62 $394 - $565	-349 Reduced 0.19%	184,870 $292,000
Q3 2022 Nov 14, 2022	BUY	$1.2 - $2.07 $9,836 - $16,967	8,197 Added 4.63%	185,219 $229,000
Q2 2022 Aug 12, 2022	BUY	$1.86 - $2.62 $4,025 - $5,669	2,164 Added 1.24%	177,022 $357,000
Q1 2022 May 13, 2022	BUY	$2.29 - $3.88 $16,247 - $27,528	7,095 Added 4.23%	174,858 $437,000
Q3 2021 Nov 12, 2021	BUY	$3.1 - $4.32 $106,001 - $147,718	34,194 Added 25.6%	167,763 $672,000
Q2 2021 Aug 13, 2021	BUY	$4.45 - $9.91 $22,699 - $50,550	5,101 Added 3.97%	133,569 $594,000
Q1 2021 May 12, 2021	BUY	$7.76 - $10.43 $192,207 - $258,340	24,769 Added 23.89%	128,468 $1.18 Million
Q4 2020 Feb 12, 2021	BUY	$4.13 - $10.14 $169,482 - $416,115	41,037 Added 65.49%	103,699 $1.05 Million
Q3 2020 Nov 13, 2020	BUY	$3.91 - $7.15 $24,437 - $44,687	6,250 Added 11.08%	62,662 $265,000
Q2 2020 Aug 13, 2020	SELL	$2.6 - $7.32 $2,891 - $8,139	-1,112 Reduced 1.93%	56,412 $390,000
Q1 2020 May 14, 2020	BUY	$2.25 - $5.64 $89,925 - $225,413	39,967 Added 227.64%	57,524 $161,000
Q4 2019 Feb 13, 2020	BUY	$1.8 - $5.04 $3,884 - $10,876	2,158 Added 14.01%	17,557 $85,000
Q3 2019 Nov 12, 2019	BUY	$2.07 - $4.88 $31,875 - $75,147	15,399 New	15,399 $31,000

Others Institutions Holding DMAC

# of Institutions

Shares Held

4.22M

Call Options Held

8.2K

Put Options Held

200

View Full List

About DiaMedica Therapeutics Inc.

Ticker DMAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,443,100
Market Cap $141M
Description
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...

More about DMAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Dia Medica Therapeutics Inc. Transaction History